mRNA |
Bosutinib |
GDSC1000 |
pan-cancer |
AAC |
-0.062 |
0.06 |
mRNA |
SR-II-138A |
CTRPv2 |
pan-cancer |
AAC |
0.059 |
0.06 |
mRNA |
navitoclax:birinapant (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.069 |
0.06 |
mRNA |
BRD1812 |
CTRPv2 |
pan-cancer |
AAC |
0.066 |
0.06 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.067 |
0.06 |
mRNA |
ABT-199 |
CTRPv2 |
pan-cancer |
AAC |
0.084 |
0.06 |
mRNA |
NSC23766 |
CTRPv2 |
pan-cancer |
AAC |
0.065 |
0.06 |
mRNA |
cabozantinib |
CTRPv2 |
pan-cancer |
AAC |
0.068 |
0.06 |
mRNA |
BRD-K09587429 |
CTRPv2 |
pan-cancer |
AAC |
0.074 |
0.06 |
mRNA |
JQ-1 |
CTRPv2 |
pan-cancer |
AAC |
0.058 |
0.06 |